| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/23/2004 | US20040258753 Exterior semipermeable memrane wherein bio-agent release or delivery is caused by explosion of membrane and begins after a lag time; and core contains bio-agent and biodegradable oligomer or polymer aqueous solution; time-release agents; drugs, proteins, vitamins, hormones, biocides, pesticides |
| 12/23/2004 | US20040258752 Taste masking pharmaceutical composition and process for its preparation |
| 12/23/2004 | US20040258751 Mixing ribavirin with excipient; pelletization; coating with material that reduces dissolution rate in water; sustained release, free-flowing |
| 12/23/2004 | US20040258750 Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof |
| 12/23/2004 | US20040258749 Side effect reduction; retarder coating; embedded in matrix; sustained release |
| 12/23/2004 | US20040258748 Compressing mixture of drug and effervescent acid source and base to produce a tablet; moisture activation; disintegration; drugs such as rofecoxib, simvastatin, olanzapine; and sodium bicarbonate |
| 12/23/2004 | US20040258747 NGR(asparagine-glycine-arginine) molecule linked to encapsulating vehicle capable of delivering folds of antitumor agents comprising doxorubicin, vincristine, mitoxantrone, calicheamicin, Iressa, or Gleevec; anticarcinogenic agents; amino-polyethylene glycol phosphatidylethanolamine derivative liposomes |
| 12/23/2004 | US20040258746 Freeze dried liposomes having antigen and of different sizes before lyophilization; orally administering to mammal; absorption in Peyer's patches of gut and taken up by macrophages; viral, fungal, and bacterial antigens; vaccines |
| 12/23/2004 | US20040258745 Pharmaceutical composition containing artificial oxygen carrier |
| 12/23/2004 | US20040258744 Surface modified lipoprotein-like oil in water emulsion having lipophilic core surrounded by monolayer of amphiphilic or polar lipids; polyoxyethylene glycol linked lipid and (choles)terol; radioactive or stable, synthetic polyhalogenated triglycerides as contrast agents; radiographic imaging |
| 12/23/2004 | US20040258742 Transdermal administration of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methyl guanidines |
| 12/23/2004 | US20040258741 Percutaneous absorption preparations |
| 12/23/2004 | US20040258740 Transdermal delivery composition |
| 12/23/2004 | US20040258739 Plaster for the treatment of dysfunctions and disorders of nails |
| 12/23/2004 | US20040258738 Treatment devices providing targeted antimicrobial action |
| 12/23/2004 | US20040258737 Method for neutralizing or recycling carrier materials for film-like coatings |
| 12/23/2004 | US20040258733 Dentifrice, chewing gum, confection, lozenge, mouthwash, mouth spray or edible film; bactericides; food acid, anticaries agent, antitartar agent, softener, plasticizer, essential oil, emulsifiers |
| 12/23/2004 | US20040258731 Preparation approriate for cartilage tissue formation |
| 12/23/2004 | US20040258725 Nontoxic pesticide, and method of using the same |
| 12/23/2004 | US20040258724 Gilsonite oil and drug for topical or transdermal drug delivery to skin or nails; penetration ehancement |
| 12/23/2004 | US20040258720 Cosmetics; skin disorders, antiinflammatory agents |
| 12/23/2004 | US20040258718 Synergistic mixed poloxamer systmes for the solubilisation of drugs |
| 12/23/2004 | US20040258716 Spill-resistant, semi-solid, aqueous pharmaceutical suspension for oral administration comprising a water-insoluble medicine in a stabilizing vehicle of glycerin, sorbitol, propylene glycol and thickener, e.g. Carbopol"; palatable; homogeneous; shelf life of <36 months; crystal growth inhibitors |
| 12/23/2004 | US20040258708 Cytotoxic T-cell epitopes of papillomavirus L1 protein and their use in diagnostics and therapy |
| 12/23/2004 | US20040258702 Immunogen formulation comprising antigen, biocompatible polymer and liquid vehicle for stimulation of an immune response; the polymer interacts with the liquid vehicle to impart reverse thermal viscosity behavior to the composition, i.e. reverse thermal gelation; potentiation |
| 12/23/2004 | US20040258701 Potentiation of the immunogenicity of animal vaccines using an adjuvant of light hydrocarbon non-metabolizable oil, surfactant, and an aqueous component; mean oil droplet size is <1 mu m.; antigens intrinsically or extrinsically combined; immunostimulants; stability; nontoxic; veterinary medicine |
| 12/23/2004 | US20040258700 A nontoxic mixture of 2-phenoxyethanol and para hydroxybenzoates, (e.g. methyl-, ethyl-, propyl- or butyl-, p-hydroxybenzoate) more effective than 2-phenoxyethanol alone (mixture, called TF-1); effect comparable to that of thiomersal or chloroform in vaccines |
| 12/23/2004 | US20040258698 Delivery of immune response modifier compounds |
| 12/23/2004 | US20040258665 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith |
| 12/23/2004 | US20040258663 Maintaining sustained levels and optimizing intranasal dosing schedules without causing intolerable side effects |
| 12/23/2004 | US20040258656 Identified via SELEX method; phosphate-containing ligand is conjugated to polyoxyethylene glycol; transforming growth factor (TGF); pharmacokinetics |
| 12/23/2004 | US20040258647 Active ingredient-containing cosmetic cleansing emulsions |
| 12/23/2004 | US20040258634 Suitable for diabetics; gum diseases |
| 12/23/2004 | US20040258626 Combination of medicament and lactose particles; accurate, uniform, consistent dispersion for multidose dry powder inhaler |
| 12/23/2004 | US20040258625 Simultaneous inhalation delivery of at least two drugs with high efficiency to targeted airways and/or lungs |
| 12/23/2004 | US20040258624 Combined doses |
| 12/23/2004 | US20040258623 Microemulsion containing soybean lecithin as absorption promoter, propylene glycol cosolvent and phosphate buffer; bioavailability, stability, low toxicity; produced by sonication |
| 12/23/2004 | US20040258622 Nonozone depleting aerosol formulation employing hydrofluoroalkane propellants |
| 12/23/2004 | US20040256760 Using compression, thermal cycle molding, and thermal setting molding modules in continuous process |
| 12/23/2004 | US20040256749 Process for production of essentially solvent-free small particles |
| 12/23/2004 | US20040256748 Dissolving tetraethyl silicate into an aqueous solution containing a hydrolysis catalyst; adding a core material and aminopropyltriethoxysilane as a gelling agent; emulsifying and dispersing; sunscreen agents solution having an o polarity opp |
| 12/23/2004 | DE19801811B4 Pharmazeutische Zubereitung zur oralen Verabreichung Pharmaceutical preparation for oral administration |
| 12/23/2004 | DE10306761B9 Verfahren zur Herstellung von sterilen pharmazeutischen Wirkstoffen A process for the preparation of sterile pharmaceutical agents |
| 12/23/2004 | DE10103860B4 Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung Transdermal therapeutic system for the administration of carboxyl-containing, non-steroidal anti-inflammatory agents, and to processes for its preparation |
| 12/23/2004 | CA2849228A1 Process for the manufacture of stable shaped particles consisting of estradiol and cholesterol |
| 12/23/2004 | CA2737127A1 Maytansinoid-antibody conjugate compositions |
| 12/23/2004 | CA2569585A1 Compositions for oral administration of campothecin and its analogs |
| 12/23/2004 | CA2539643A1 Improved system and method for facilitating hemostasis with an absorbable sponge |
| 12/23/2004 | CA2529493A1 Administration of medicinal dry powders |
| 12/23/2004 | CA2529479A1 Microcapsules for the administration of active ingredients |
| 12/23/2004 | CA2529225A1 Pharmaceutical composition and method for alleviating side effects of estrogen replacement therapy |
| 12/23/2004 | CA2529127A1 Combined doses of tiotropium and fluticasone |
| 12/23/2004 | CA2528863A1 Combined doses |
| 12/23/2004 | CA2528552A1 Pharmaceutical compositions comprising active vitamin d compounds |
| 12/23/2004 | CA2528545A1 Process for the manufacture of stable shaped particles consisting of estradiol and cholesterol |
| 12/23/2004 | CA2528479A1 Formoterol and ciclesonide combination |
| 12/23/2004 | CA2528418A1 Method to increase protein production in culture |
| 12/23/2004 | CA2528413A1 Radial spherical crystallization product, process for producing the same and dry powder preparation containing the crystallization product |
| 12/23/2004 | CA2528378A1 Treatment of immune-mediated disorders with active vitamin d compounds alone or in combination with other therapeutic agents |
| 12/23/2004 | CA2528359A1 Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments |
| 12/23/2004 | CA2528249A1 Orally-dispersible multilayer tablet |
| 12/23/2004 | CA2527735A1 Functionally reconstituted viral membranes containing adjuvant |
| 12/23/2004 | CA2527625A1 Method of pulmonary administration of an agent |
| 12/23/2004 | CA2527368A1 Pharmaceutical composition |
| 12/23/2004 | CA2526567A1 Oil emulsion for postnatal hormone substitution |
| 12/23/2004 | CA2526416A1 Polyanionic polymer adjuvants for haemophilus influenza b saccharide vaccines |
| 12/23/2004 | CA2526101A1 Implantable polymeric device for sustained release of nalmefene |
| 12/23/2004 | CA2525786A1 Preparation-at-use device comprising pre-formed hydrogel product |
| 12/23/2004 | CA2524639A1 Compositions and methods for reducing scar tissue formation |
| 12/22/2004 | EP1489184A1 Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer |
| 12/22/2004 | EP1489183A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells |
| 12/22/2004 | EP1489125A1 Compound of hydrophilic polymer-polycarboxyl oligopeptide and medicines, medical composite comprising above compound and use of above compound in medicimes |
| 12/22/2004 | EP1488813A1 Compositions for delivering biologically active drug and method of using the same |
| 12/22/2004 | EP1488812A1 Liquid matrix undergoing phase transfer in vivo and liquid oral preparations |
| 12/22/2004 | EP1488811A1 Tablets quickly disintegrating in oral cavity |
| 12/22/2004 | EP1488810A1 Percutaneous absorption promoters and compositions for treating athlete's foot |
| 12/22/2004 | EP1488801A1 Chemical igf-i composition for the treatment and prevention of neurodegenerative diseases |
| 12/22/2004 | EP1488800A1 Agent for the treatment of protozoal diseases |
| 12/22/2004 | EP1488797A2 Oral preprations having itching-relievign or antipruritic activity |
| 12/22/2004 | EP1488790A1 Solid preparation containing single crystal form |
| 12/22/2004 | EP1488789A1 Eye drops containing tetrazole derivative |
| 12/22/2004 | EP1488787A1 Topical stabilized formulations containing ketoprofen |
| 12/22/2004 | EP1488786A1 Melt-extruded orally administrable opioid formulations |
| 12/22/2004 | EP1488785A1 Oil emulsion for postnatal substitution of hormones |
| 12/22/2004 | EP1488784A1 Male contraceptive implant |
| 12/22/2004 | EP1488761A1 Device for delivering a therapeutic agent to a blood vessel |
| 12/22/2004 | EP1487992A2 Central airway administration for systemic delivery of therapeutics |
| 12/22/2004 | EP1487892A1 Amphiphilic diblock, triblock and star-block copolymers and their pharmaceutical compositions |
| 12/22/2004 | EP1487840A1 Crystalline polymorphic form of irinotecan hydrochloride |
| 12/22/2004 | EP1487832A1 Micronized crystalline tiotropium bromide |
| 12/22/2004 | EP1487791A1 A novel antifungal molecule 2-(3,4-dimethyl-2,5-dihydro-1h-pyrrol-2-yl)- methylethyl pentanoate |
| 12/22/2004 | EP1487540A2 Storage stable eplerenone formulation |
| 12/22/2004 | EP1487531A2 Coated microfluidic delivery system |
| 12/22/2004 | EP1487506A2 Preparation for wound healing and prevention of bandage adhesion to the wound |
| 12/22/2004 | EP1487498A1 Topical composition comprising a cyclofructan, a carrier and a drug |
| 12/22/2004 | EP1487496A1 Test system for evaluating the compatibility of biologically active substances with copolymers |
| 12/22/2004 | EP1487486A2 Imidazoquinolineamines as adjuvants in hiv dna vaccination |
| 12/22/2004 | EP1487474A2 Intranasal administration of mc4-r agonists |
| 12/22/2004 | EP1487469A1 Co-beadlet of dha and rosemary and methods of use |
| 12/22/2004 | EP1487462A2 Preparations for topical skin use and treatment |